<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01473992</url>
  </required_header>
  <id_info>
    <org_study_id>6140101200</org_study_id>
    <nct_id>NCT01473992</nct_id>
  </id_info>
  <brief_title>Comparative Outcomes Assessment of the C-Leg With a New Knee Prosthesis</brief_title>
  <official_title>Comparative Outcomes Assessment of the C-Leg With a New Knee Prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jason Highsmith</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Otto Bock Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Florida High Tech Corridor Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of South Florida</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if transfemoral amputees of varied etiology will
      demonstrate increased function, safety and quality of life following accommodation with a new
      knee prosthesis as compared to their former C-Leg knee prosthesis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>75 Meter Self Selected Walking Test</measure>
    <time_frame>Based on preliminary experience with the intervention, accommodation can range from 2 weeks to 3 months. Assessment will be scheduled within 2 weeks following accommodation.</time_frame>
    <description>Time to Complete a 75 meter walking distance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physical Functional Performance (Continuous Scale; 10-items)</measure>
    <time_frame>Accommodation with knee systems is approximately 90 days. This test takes less than 1hr to complete.</time_frame>
    <description>Simulation of 10 activities of daily living (i.e. donning a shirt, sweeping, walking stairs). Measured in units of time, distance and mass to provide a singular, continuous scaled score of function (from 0-100). A score of 100 is the maximal score and indicates the highest level of independent function where a score of 0 indicates the poorest score. Persons scoring lower scores will likely be at increased risk of dependency with daily function.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Balance and Stability</measure>
    <time_frame>Based on preliminary experience with the intervention, accommodation can range from 2 weeks to 3 months. Assessment will be scheduled within 2 weeks following accommodation.</time_frame>
    <description>Balance and stability will be assessed for limits of stability using the Biodex SD. The limit of stability score is a scaled score with a possible range of 0 (worst possible outcome) to 100 (best possible outcome)based on variability of the trajectory of the center of mass while weight shifting on a force platform.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthesis Evaluation Questionnaire: Utility Score.</measure>
    <time_frame>Based on preliminary experience with the intervention, accommodation can range from 2 weeks to 3 months. Assessment will be scheduled within 2 weeks following accommodation.</time_frame>
    <description>The Prosthetics Evaluation Questionnaire (PEQ) was used as a validated survey to solicit participants' subjective experience and feedback regarding prosthesis-related function and quality of life. PEQ domains are ordinally scaled from 0 (worst or most negative feeling/response) to 7 (best or most positive feeling/response).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Other and Unspecified Complications of Amputation Stump</condition>
  <arm_group>
    <arm_group_label>Prosthetic knee 1 (Otto Bock C-Leg)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm included unilateral transfemoral amputees who were assessed while using their preferred knee at study start(C-Leg). The Otto Bock C-Leg is a microprocessor knee using 2 sensors (1 for kinetics and 1 for kinematics).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prosthetic knee 2 (Otto Bock Genium)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm included unilateral transfemoral amputees who were assessed while using the experimental/study knee, the Genium. The Otto Bock Genium is a microprocessor knee using multiple sensors that hypothetically increase mobility functions (e.g. walking backwards, intuitive stance)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-amputee controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This was an observational arm including non-amputees who were assessed as non-impaired control subjects. There are no interventions in this observational arm of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Otto Bock C-Leg</intervention_name>
    <description>Amputees' preferred prosthetic knee.</description>
    <arm_group_label>Prosthetic knee 1 (Otto Bock C-Leg)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Otto Bock Genium</intervention_name>
    <description>Study knee.</description>
    <arm_group_label>Prosthetic knee 2 (Otto Bock Genium)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Unilateral transfemoral or knee-disarticulation amputee

          -  18 to 85 years of age

          -  K3 (variable cadence and community) ambulators;

          -  Current use of and experience with the C-Leg for at least 1 year

          -  Ability to descend stairs and hills without caregiver and assistive devices

          -  Be able to independently provide informed consent

          -  Be willing to comply with study procedures.

        Exclusion criteria:

          -  History of chronic skin breakdown on the residual limb

          -  Conditions that would prevent participation and pose increased risk (e.g. unstable
             cardiovascular conditions that preclude physical activity such as walking)

          -  Use of any assistive devices/walking aids, beyond a prosthesis, to ambulate

          -  Unwillingness/inability to follow instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M. Jason Highsmith, PT,DPT,CP</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of South Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2011</study_first_submitted>
  <study_first_submitted_qc>November 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2011</study_first_posted>
  <results_first_submitted>May 6, 2014</results_first_submitted>
  <results_first_submitted_qc>November 17, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 18, 2014</results_first_posted>
  <last_update_submitted>November 20, 2014</last_update_submitted>
  <last_update_submitted_qc>November 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of South Florida</investigator_affiliation>
    <investigator_full_name>Jason Highsmith</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Prosthetic Knee 1 Then Prosthetic Knee 2</title>
          <description>Otto Bock C-Leg: Amputees' preferred prosthetic knee then experimental knee (Genium).</description>
        </group>
        <group group_id="P2">
          <title>Prosthetic Knee 2 Then Prosthetic Knee 1</title>
          <description>Experimental knee (Otto Bock Genium: Study knee) then subjects' preferred knee (C-Leg).</description>
        </group>
        <group group_id="P3">
          <title>Control (Non-amputees)</title>
          <description>Non-amputee control group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Entire Study Population</title>
          <description>Includes groups randomized to receive Otto Bock C-Leg (prosthetic knee 1), amputees' preferred prosthetic knee, first and Otto Bock Genium (prosthetic knee 2), the study knee, first.</description>
        </group>
        <group group_id="B2">
          <title>Non Amputee Control Group</title>
          <description>non-amputee healty controls</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.5" spread="14.2"/>
                    <measurement group_id="B2" value="57.2" spread="15.7"/>
                    <measurement group_id="B3" value="51.9" spread="15.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>75 Meter Self Selected Walking Test</title>
        <description>Time to Complete a 75 meter walking distance.</description>
        <time_frame>Based on preliminary experience with the intervention, accommodation can range from 2 weeks to 3 months. Assessment will be scheduled within 2 weeks following accommodation.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prosthetic Knee 1</title>
            <description>Otto Bock C-Leg: Amputees' preferred prosthetic knee.</description>
          </group>
          <group group_id="O2">
            <title>Prosthetic Knee 2</title>
            <description>Otto Bock Genium: Study knee.</description>
          </group>
          <group group_id="O3">
            <title>Non Amputee Control Group</title>
            <description>healthy, non-amputee controls</description>
          </group>
        </group_list>
        <measure>
          <title>75 Meter Self Selected Walking Test</title>
          <description>Time to Complete a 75 meter walking distance.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.1" spread="10.2"/>
                    <measurement group_id="O2" value="64.0" spread="10.3"/>
                    <measurement group_id="O3" value="54.0" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Balance and Stability</title>
        <description>Balance and stability will be assessed for limits of stability using the Biodex SD. The limit of stability score is a scaled score with a possible range of 0 (worst possible outcome) to 100 (best possible outcome)based on variability of the trajectory of the center of mass while weight shifting on a force platform.</description>
        <time_frame>Based on preliminary experience with the intervention, accommodation can range from 2 weeks to 3 months. Assessment will be scheduled within 2 weeks following accommodation.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prosthetic Knee 1</title>
            <description>Otto Bock C-Leg: Amputees' preferred prosthetic knee.</description>
          </group>
          <group group_id="O2">
            <title>Prosthetic Knee 2</title>
            <description>Otto Bock Genium: Study knee.</description>
          </group>
          <group group_id="O3">
            <title>Non Amputee Control Group</title>
            <description>healthy, non-amputee controls</description>
          </group>
        </group_list>
        <measure>
          <title>Balance and Stability</title>
          <description>Balance and stability will be assessed for limits of stability using the Biodex SD. The limit of stability score is a scaled score with a possible range of 0 (worst possible outcome) to 100 (best possible outcome)based on variability of the trajectory of the center of mass while weight shifting on a force platform.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.7" spread="24.3"/>
                    <measurement group_id="O2" value="59.2" spread="25.4"/>
                    <measurement group_id="O3" value="73.1" spread="21.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prosthesis Evaluation Questionnaire: Utility Score.</title>
        <description>The Prosthetics Evaluation Questionnaire (PEQ) was used as a validated survey to solicit participants' subjective experience and feedback regarding prosthesis-related function and quality of life. PEQ domains are ordinally scaled from 0 (worst or most negative feeling/response) to 7 (best or most positive feeling/response).</description>
        <time_frame>Based on preliminary experience with the intervention, accommodation can range from 2 weeks to 3 months. Assessment will be scheduled within 2 weeks following accommodation.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prosthetic Knee 1</title>
            <description>Otto Bock C-Leg: Amputees' preferred prosthetic knee.</description>
          </group>
          <group group_id="O2">
            <title>Prosthetic Knee 2</title>
            <description>Otto Bock Genium: Study knee.</description>
          </group>
        </group_list>
        <measure>
          <title>Prosthesis Evaluation Questionnaire: Utility Score.</title>
          <description>The Prosthetics Evaluation Questionnaire (PEQ) was used as a validated survey to solicit participants' subjective experience and feedback regarding prosthesis-related function and quality of life. PEQ domains are ordinally scaled from 0 (worst or most negative feeling/response) to 7 (best or most positive feeling/response).</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" lower_limit="2" upper_limit="7"/>
                    <measurement group_id="O2" value="5.5" lower_limit="2" upper_limit="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Physical Functional Performance (Continuous Scale; 10-items)</title>
        <description>Simulation of 10 activities of daily living (i.e. donning a shirt, sweeping, walking stairs). Measured in units of time, distance and mass to provide a singular, continuous scaled score of function (from 0-100). A score of 100 is the maximal score and indicates the highest level of independent function where a score of 0 indicates the poorest score. Persons scoring lower scores will likely be at increased risk of dependency with daily function.</description>
        <time_frame>Accommodation with knee systems is approximately 90 days. This test takes less than 1hr to complete.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Prosthetic Knee 1</title>
            <description>Otto Bock C-Leg: Amputees' preferred prosthetic knee.</description>
          </group>
          <group group_id="O2">
            <title>Prosthetic Knee 2</title>
            <description>Otto Bock Genium: Study knee.</description>
          </group>
          <group group_id="O3">
            <title>Non Amputee Control Group</title>
            <description>healthy, non-amputee control group</description>
          </group>
        </group_list>
        <measure>
          <title>Physical Functional Performance (Continuous Scale; 10-items)</title>
          <description>Simulation of 10 activities of daily living (i.e. donning a shirt, sweeping, walking stairs). Measured in units of time, distance and mass to provide a singular, continuous scaled score of function (from 0-100). A score of 100 is the maximal score and indicates the highest level of independent function where a score of 0 indicates the poorest score. Persons scoring lower scores will likely be at increased risk of dependency with daily function.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.2" spread="14.8"/>
                    <measurement group_id="O2" value="59.6" spread="16.0"/>
                    <measurement group_id="O3" value="73.04" spread="15.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Prosthetic Knee 1</title>
          <description>Otto Bock C-Leg: Amputees' preferred prosthetic knee.</description>
        </group>
        <group group_id="E2">
          <title>Prosthetic Knee 2</title>
          <description>Otto Bock Genium: Study knee.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>M. Jason Highsmith</name_or_title>
      <organization>University of South Florida</organization>
      <phone>8139743806</phone>
      <email>mhighsmi@health.usf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

